Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational TrialJohn M.S. Bartlett, Daniel Rea, Lucinda Billingham et al.|Journal of Clinical Oncology|2011Cited by 199
Automated image analysis for high‐throughput quantitative detection of ER and PR expression levels in large‐scale clinical studies: The TEAM Trial ExperienceDana Faratian, John M.S. Bartlett, Charlene Kay et al.|Histopathology|2009Cited by 57